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Introduction
Centrosomes play fundamental roles in regulating chromosome 
segregation and the interphase microtubule cytoskeleton. Ani-
mal cells enter mitosis with two centrosomes, which assemble a 
bipolar spindle to facilitate chromosome segregation. Centro-
somes assemble from centrioles that, like DNA, are duplicated 
once and only once per cell cycle (Fig. S1 A, available at http://
www.jcb.org/cgi/content/full/jcb.200808049/DC1;  Wong  and 
Stearns, 2003). Errors in centriole duplication lead to cells with 
too many or too few centrosomes; the resulting monopolar or 
multipolar spindles disrupt chromosome segregation and can 
lead to genomic instability (Brinkley, 2001). Interestingly, there 
is a correlation between excess centrosomes, aneuploidy, and 
cancer (Nigg, 2006), but which is the cause or consequence is 
unclear. Thus, understanding regulatory mechanisms governing 
centrosome duplication may provide insights into both normal 
cell behavior and tumorigenesis.
To prevent centriole overduplication, eukaryotic cells pos-
sess a robust mechanism that blocks reduplication (Hinchcliffe 
et al., 1998; Wong and Stearns, 2003; Tsou and Stearns, 2006a). 
The mechanism preventing centriole reduplication remains un-
clear, but analogies to DNA replication may provide insight. 
During S phase, several mechanisms prevent DNA rereplication 
(Blow and Dutta, 2005). One utilizes Cullin-based E3 ubiquitin 
ligases, which control the specificity and timing of protein deg-
radation by tagging substrates with ubiquitin, targeting them for 
proteasomal proteolysis (Deshaies, 1999). During DNA repli-
cation, E3 ubiquitin ligases mediate the destruction of replication-
initiation factors to prevent origin refiring (DePamphilis et al., 
2006). Thus, we thus explored whether centriole replication 
might be similarly controlled by E3 ubiquitin ligases.
The best characterized Cullin-based E3 ligases are the Skp/
Cullin/F box (SCF) family (Deshaies, 1999). SCF ligases are a 
complex of four subunits (Roc–Cullin–Skp–F box), each encoded 
by a multigene family. A Roc–Cullin–Skp complex forms the 
ubiquitin ligase core, whereas F-box proteins are interchange-
able substrate-binding subunits that dictate substrate specificity. 
Interestingly,  genetic  studies  in  Drosophila  melanogaster  and 
mice revealed that mutations in SCF components, including 
Drosophila skpA or the F-box genes slimb or skp2, all lead to 
supernumerary  centrosomes  (Nakayama  et  al.,  2000;  Wojcik   
et al., 2000; Guardavaccaro et al., 2003; Murphy, 2003). Fur-
thermore, mammalian Skp1 and Cul1 localize to centrosomes 
  R
estricting  centriole  duplication  to  once  per  cell   
cycle is critical for chromosome segregation and 
genomic stability, but the mechanisms underlying 
this block to reduplication are unclear. Genetic analyses 
have  suggested  an  involvement  for  Skp/Cullin/F  box 
(SCF)-class ubiquitin ligases in this process. In this study, 
we describe a mechanism to prevent centriole reduplica-
tion in Drosophila melanogaster whereby the SCF E3 
ubiquitin ligase in complex with the F-box protein Slimb 
mediates  proteolytic  degradation  of  the  centrosomal 
regulatory kinase Plk4. We identified SCF
Slimb as a regu-
lator of centriole duplication via an RNA interference 
(RNAi)  screen  of  Cullin-based  ubiquitin  ligases.  We 
found that Plk4 binds to Slimb and is an SCF
Slimb target. 
Both Slimb and Plk4 localize to centrioles, with Plk4 lev-
els highest at mitosis and absent during S phase. Using 
a Plk4 Slimb-binding mutant and Slimb RNAi, we show 
that Slimb regulates Plk4 localization to centrioles during 
interphase, thus regulating centriole number and ensur-
ing the block to centriole reduplication.
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Figure 1.  slimb RNAi elevates centriole number. (A) Effects of slimb RNAi are not solely via effects on cell cycle. Cells stained for D-PLP (red) and DNA 
(blue) were quantitated for DNA content by HTM (5,000 cells/histogram). Centrioles were manually counted in 150 randomly selected cells with 2C, 
4C, or 8C DNA. Example cells and mean, median, and range of centriole numbers are shown below sampled histogram regions. Histograms are not 227 PLK4 DEGREDATION BLOCKS CENTRIOLE REDUPLICATION • Rogers et al.
shown to scale. Asterisks denote a significant difference; *, P < 0.007 (unpaired t test). Slimb or E2F1 depletion eliminates the 8C population. (B) Cell cycle 
progression (assessed via HTM; 5,000 cells/histogram) and centriole number were scored in day 7 RNAi-treated cells. D-PLP–labeled centrioles (red) were 
manually counted. Histograms are shown to scale. (C) Unique centriole configurations in Slimb-depleted cells that contained more than the mean number 
of D-PLP–labeled centrioles (red). White tracing marks cell borders. Insets show centrioles at a higher magnification. (A–C) Bars, 5 µm. (D–F) Transmission 
electron micrographs of interphase Slimb-depleted cells. (D) Typical centriolar microtubule arrangement of the centriole in cross section (red arrow). Other 
centrioles are sagittal sections oriented in different manners. Excess centrioles in rows (E) and clusters (F).
 
(Freed et al., 1999), and chemical inhibition of proteasomes pro-
motes abnormal centriole overduplication in human cells (Duensing 
et al., 2007). These data implicate at least two complexes (SCF
Slimb 
and SCF
Skp2) in regulating centrosome duplication, but the iden-
tity of the target involved remains unknown. In this study, we re-
port that SCF
Slimb regulates centriole duplication by targeting the 
key centrosomal regulator Plk4 for proteolytic degradation, thus 
contributing to the centrosome reduplication block.
Results
An RNAi screen for Cullin-based ligases 
that limit centriole duplication  
identifies SCF
Slimb
We examined roles of Cullin-based ubiquitin ligases in centriole 
duplication using functional genomics in cultured Drosophila S2 
cells. We identified all members of the Roc–Cullin–Skp–F-box 
gene families in Drosophila, revealing 3 Roc (Noureddine et al., 
2002), 6 Cullin, 7 Skp, and 42 F-box genes. We used RNAi to 
deplete each protein (when antibodies were available, we con-
firmed RNAi depletion by immunoblotting; Fig. S1 B) and   
applied two sequential functional screens to measure changes   
in centrosome or centriole number. In the first screen, we counted 
-tubulin–labeled centrosomes in mitotic cells. 4 of 58 genes 
scored positive: skpA, skpB, slimb, or skp2 RNAi increased cen-
trosome number (Table S1, available at http://www.jcb.org/cgi/
content/full/jcb.200808049/DC1). All  other  RNAi  treatments 
yielded wild-type centrosome numbers; none decreased centro-
some number. However, the RNAi of some SCF subunits (Roc1a, 
cul-1, and rca1) induced interphase arrest, as SCF regulates cell 
cycle progression (Vodermaier, 2004), preventing assessment of 
their roles. To circumvent this and verify positives from the first 
screen, we used a second screen to measure changes in inter-
phase centriole number by immunostaining for the centriole 
protein Drosophila pericentrin-like protein (D-PLP; Fig. S1 C; 
Martinez-Campos et al., 2004). D-PLP is not only a centriolar 
protein  but  also  a  component  of  the  pericentriolar  material 
(PCM; Martinez-Campos et al., 2004); however, centrioles in 
interphase S2 cells do not recruit PCM, nor do they nucleate 
microtubule growth (Rogers et al., 2008). Thus, D-PLP marks 
centrioles in these cells. In this assay, only depletion of the ca-
nonical SCF core subunits Roc1a/Cul-1/SkpA and the F-box 
protein Slimb elevated both mean and median number of D-PLP 
spots. We note that control cells possess a higher than expected 
mean mitotic centrosome number (3.2 ± 3.0; range of 0–36 per 
cell) and interphase centriole number (3.1 ± 3.0; range of 0–25 
per cell). This is partially caused by a fraction (10%) of poly-
ploid cells that apparently spontaneously arise in an S2 cell 
population and contain numerous centrioles (Fig. 1 A). In spite 
of this, many cells (45%) contain two D-PLP spots (Fig. S2 B). 
We confirmed the increased centriole number using EGFP–SAS-6 
as a centriole marker; median centriole number increased by 
one after Slimb depletion (n = 194 cells examined). Slimb de-
pletion also increased multipolar spindle frequency (Fig. S1 D), 
which is consistent with increased centrosome number. These 
data suggest that no single Cullin or identifiable Cullin-based 
ubiquitin ligase component is essential for centriole duplication 
in S2 cells and that SCF
Slimb suppresses centriole overduplication. 
Furthermore, these data are consistent with previously published 
work implicating Slimb/-Trcp1 and SkpA in regulating cen-
trosome number in Drosophila and mammalian cells (Wojcik 
et al., 2000; Guardavaccaro et al., 2003; Murphy, 2003).
Slimb plays a separate role in cell cycle 
progression, limiting the extent of  
centriole overduplication
Because Slimb has been implicated in cell cycle progression 
(Wojcik et al., 2000), we examined whether elevated centriole 
number was simply an indirect consequence of altering the cell 
cycle. Drosophila centrioles, like their counterparts in mamma-
lian cells, duplicate during S phase and disengage during telo-
phase (Fig. S2 A). The centriole markers available in Drosophila 
do not allow us to resolve centriole singlets from pairs because 
of their close association after duplication. Thus, we used D-PLP 
to mark centrioles, with the caveat that a D-PLP spot could   
represent either a centriole singlet or a doublet before dis-
engagement. To test whether cell cycle alterations caused the 
differences in apparent centriole number we observed in slimb 
mutants, we developed a high-throughput microscopy (HTM) 
assay to simultaneously quantitate DNA and centriole number. 
RNAi-treated cells were stained with DAPI and anti–D-PLP 
and scanned by HTM to measure DNA content, thus assessing 
centriole number at each cell cycle stage (Fig. 1 A and Fig. S2 C). 
Wild-type cells with either 2C (G1 phase) or 4C (G2 and M 
phases) DNA content had similar centriole numbers because we 
cannot distinguish the centriole singlets and doublets present at 
these respective cell cycle phases.
Strikingly, Slimb depletion elevated centriole numbers in 
both 2C (G1 phase) and 4C (G2 and M phases) populations 
(Fig. 1 A). However, it also increased the fraction of G1-phase 
(2C) cells. Because Slimb depletion affects both centriole num-
ber and causes G1 arrest, we tested whether increased centriole 
number is solely an indirect effect of increasing the fraction of 
G1-phase cells. This was not the case, as RNAi of E2F1, a tran-
scription factor required for G1 to S-phase progression (Dimova 
et al., 2003), also increased G1-phase cells without elevating 
centriole number (Fig. 1 A).
Cdk2–cyclin E activity is high during S phase, when it is 
required for centriole duplication (Winey, 1999), and low during 
G1 phase, limiting G1 centriole duplication. We hypothesized JCB • VOLUME 184 • NUMBER 2 • 2009   228
gation (Fig. 2 F). These data demonstrate that Slimb associates 
with centrioles. In addition, we noted that Slimb occasionally 
appeared asymmetrically positioned on centrioles in live cells 
(Fig. 2 D and Video 1, available at http://www.jcb.org/cgi/ 
content/full/jcb.200808049/DC1). However, centrioles in these 
cells are not stationary but instead constantly spin and move ap-
parently randomly throughout the cell (Rogers et al., 2008). 
Thus, this perceived asymmetry in Slimb localization on centri-
oles is likely the result of a delay in image acquisition using live 
cell microscopy.
Next, we examined Slimb localization to centrioles during 
specific cell cycle phases, as centriole duplication is an event 
tightly coupled to cell cycle progression (Fig. 2 F). Thus, we 
chemically arrested cells during S, G2, and M phases and exam-
ined Slimb protein levels and centriole localization. Strikingly, 
Slimb immunostaining to centrioles was apparently not cell   
cycle regulated, as Slimb localized to centrioles during these 
cell cycle stages (Fig. 2 F). Similarly, quantitative immunoblots 
revealed that total Slimb levels are relatively high throughout 
these phases, peaking during G2 and remaining elevated during 
mitosis (Fig. 2 G). Thus, Slimb associates with centrioles dur-
ing all of the cell cycle phases that we examined.
The tumor suppressor Plk4 is a target for 
Slimb-mediated ubiquitination
We  hypothesized  that  SCF
Slimb  depletion  stabilizes  a  central 
regulator of centriole duplication, promoting overduplication. 
The kinase Plk4 (also called Sak), a tumor suppressor (Ko et al., 
2005), is essential for centriole duplication, and Plk4 over-
expression produces supernumerary centrioles (Bettencourt-Dias 
et al., 2005; Habedanck et al., 2005; Kleylein-Sohn et al., 2007; 
Peel et al., 2007; Rodrigues-Martins et al., 2007). Thus, we ex-
plored whether Plk4 is an SCF
Slimb target. Consistent with this 
hypothesis, we identified a potential Slimb-binding site on Dro-
sophila Plk4 downstream of the kinase domain; this sequence 
(DSGIIT) fits the Slimb-binding consensus (DpSGXXp[S/T]) 
and is conserved in vertebrate Plk4 orthologues (Fig. 3 A).
As a first test of the hypothesis that Plk4 is a Slimb target, 
we examined whether Slimb coimmunoprecipitated with Plk4 
from a stable S2 cell line expressing Plk4-myc. Affinity-purified 
anti-Slimb antibodies, but not preimmune antisera, immunopre-
cipitated endogenous Slimb and coimmunoprecipitated the SCF 
protein SkpA and Plk4-myc (Fig. 3 B). Likewise, in the recipro-
cal experiment, anti-GFP antibody coimmunoprecipitated en-
dogenous Slimb from cells expressing Plk4-EGFP (Fig. 3 C, 
left). Thus, Plk4 associates with Slimb.
The putative Slimb-binding consensus in Plk4 suggests 
that Plk4 could directly bind Slimb and be a ubiquitination sub-
strate (Fig. 3 A). To test this, we generated a Slimb-binding   
mutant  (SBM)  of  Plk4  (Plk4-SBM–EGFP),  mutating  two   
key residues in the binding consensus, changing DSGIIT to   
DAGIIA (S293A/T297A). Phosphorylation of these serine and 
threonine residues is typically required for Slimb recognition 
and ubiquitination (Smelkinson and Kalderon, 2006). Anti-GFP 
antibody immunoprecipitated Plk4-SBM–EGFP but did not co-
immunoprecipitate endogenous Slimb (Fig. 3 C, right). Further-
more, when coexpressed with triple Flag-tagged fly ubiquitin, 
that slimb RNAi–mediated G1 arrest may limit the cell’s capac-
ity to produce more centrioles, thus underestimating Slimb’s 
role  in  restricting  centriole  reduplication.  To  fully  uncover 
Slimb’s role, we bypassed the putative G1 arrest by simultane-
ously depleting the cyclin-dependent kinase inhibitor Dacapo 
that establishes G1 phase in Drosophila (de Nooij et al., 1996; 
Lane et al., 1996). dacapo RNAi alone did not appreciably alter 
cell cycle distribution or centriole number (Fig. 1 B and Fig. S1 C). 
However, codepleting Slimb and Dacapo alleviated the G1 
arrest caused by slimb RNAi alone and restored cell cycle pro-
gression (Fig. 1 B). Strikingly, it also further increased centriole 
number compared with slimb RNAi alone (Fig. 1 B and Fig. S1 C), 
suggesting that Slimb plays separate roles in limiting centriole 
duplication and in cell cycle progression.
These data are consistent with two different possible ef-
fects of Slimb depletion. First, Slimb might normally restrain 
centriole duplication to once per cell cycle. Second, Slimb de-
pletion might lead to premature centriole disengagement; be-
cause  we  cannot  distinguish  centriole  singlets  and  doublets 
using light microscopy, this would create the appearance of more 
centrioles. To determine whether the increase in D-PLP spots 
represents overduplication of bona fide centrioles, we examined 
centriole morphology in Slimb-depleted cells by both light mi-
croscopy and EM. By EM, centrioles in Slimb-depleted cells 
had  the  characteristic  cylindrical  shape  with  nine  doublet   
microtubules (Fig. 1 D). This suggests that the steps of centriole 
duplication  most  likely  occur  normally.  However,  Slimb- 
depleted cells differed from wild type in another significant way. 
In wild type, 28 of 29 centrioles imaged by EM were normal 
singlets or doublets. In contrast, in Slimb-depleted cells, six of 
nine centrioles imaged by EM had multiple centrioles in clus-
ters, which is inconsistent with either a normal singlet or dou-
blet. Mutant cells that contained more than a mean number of 
centrioles had these centrioles arranged in discrete centriole 
chains or clusters, which could be visualized either at the EM or 
light levels (at the light level, 30% of Slimb-depleted cells had 
interphase centriole clusters [n = 98], whereas no control cells 
had these [n = 100]; Fig. 1, C, E, and F). Together, these data 
suggest that the putative Slimb target is likely a key regulator of 
centriole duplication, which is consistent with earlier work in 
vivo that also supported a role in centriole duplication and not 
simply in disengagement (Wojcik et al., 2000).
Slimb localizes to centrioles
We hypothesized that if Slimb regulates centriole duplication, it 
might localize to centrioles. To test this, we generated antisera 
specifically  recognizing  Slimb  (Fig.  2, A  and  B). Although 
mostly  cytoplasmic,  Slimb  was  enriched  on  D-PLP–labeled 
centrioles in interphase S2 cells (Fig. 2 C). In contrast, Slimb 
immunostaining  at  centrioles  was  significantly  reduced  by 
Slimb depletion (Fig. S2 D). To confirm this localization, we 
examined an S2 stable line expressing both Slimb-EGFP and 
mCherry–SAS-6 (a centriole protein; Rusan and Peifer, 2007). 
Like Slimb, Slimb-EGFP was enriched at mCherry–SAS-6–
labeled centrioles in live interphase cells (Fig. 2 D). Further-
more,  a fraction of both endogenous and EGFP-tagged Slimb 
copurified with centrioles isolated using sucrose gradient centrifu-229 PLK4 DEGREDATION BLOCKS CENTRIOLE REDUPLICATION • Rogers et al.
slimb RNAi (Fig. 3 E and Fig. S3 A, available at http://www.jcb 
.org/cgi/content/full/jcb.200808049/DC1). Thus, Slimb normally 
down-regulates Plk4 levels.
Because mutation of two putatively phosphorylated resi-
dues within the Slimb-binding consensus abolished both Slimb 
binding and ubiquitination, we next examined the phosphory-
lation state of Plk4 in cells containing or depleted of Slimb. 
Plk4-EGFP expressed in control cells migrates as an 110-kD 
polypeptide (Fig. 3 F, left). Markedly, Slimb depletion led to the 
appearance of an abundant slower migrating species of Plk4 
immunoprecipitated Plk4-EGFP was labeled with Flag-ubiquitin, 
whereas Plk4-SBM–EGFP was not (Fig. 3 D). These data sug-
gest that association and ubiquitination occurs via a phosphory-
lated Slimb-binding domain in Plk4.
If Plk4 is a Slimb target, Slimb depletion should stabilize 
Plk4. To assess this, we generated an S2 stable line expressing 
Plk4-EGFP and measured Plk4 levels by immunoblotting for 
GFP after depleting different F-box proteins. Whereas Plk4-
EGFP levels were extremely low in control or cells depleted of 
the F-box proteins Skp2 or Ago, Plk4-EGFP accumulated after 
Figure 2.  Slimb localizes to centrioles. (A) Immunoblot of affinity-purified anti-Slimb antibody against an S2 cell lysate. (B) slimb RNAi depletes protein 
by 98%. (C and C) Immunostaining of Slimb (green, monochrome) and D-PLP centrioles (red) in interphase S2 cells. (D and D) Stable S2 line expressing 
Slimb-EGFP (green, monochrome) and mCherry–SAS-6 centrioles in live interphase cells. (C–D) Centrioles (arrowheads) are shown at a higher magni-
fication (insets). (E) Endogenous Slimb and Slimb-EGFP cosediment with centrioles purified from S2 cells on a 20–70% sucrose gradient. Fractions were   
immunoblotted for D-PLP, GFP, and Slimb. Asterisks denote peak centriole-containing fractions. (F) Slimb (green, arrowheads) immunolocalizes to D-PLP   
centrioles (red) after 24-h drug-induced S-, G2-, or M-phase arrest. Histograms (to scale) of DNA content assessed by HTM (5,000 cells/histogram). Condensed 
DNA (blue) reveals a mitotic cell. Insets show centrioles at a higher magnification. (G) Graph of endogenous Slimb levels after 24-h drug-induced cell cycle 
arrest as determined from quantitative anti-Slimb immunoblots (below graph). (B and G) -Tubulin was used as a loading control. Bars, 5 µm.JCB • VOLUME 184 • NUMBER 2 • 2009   230
results strongly suggest that Slimb binds and ubiquitinates a 
phosphorylated form of Plk4.
Based on these data, we hypothesized that Plk4 acts down-
stream of Slimb to regulate centriole duplication. If increased 
centriole number in Slimb-depleted cells requires Plk4, centri-
ole number should not increase in double-depleted cells. We 
monitored Plk4 depletion by immunoblotting for GFP in a sta-
ble cell line expressing Plk4-EGFP under control of the weak 
(Fig. 3 F, left). To test whether phosphorylation accounted for 
the slow migration of this new form of Plk4-EGFP, we immuno-
precipitated Plk4-EGFP from Slimb-depleted cells and analyzed 
its migration in SDS-PAGE after alkaline phosphatase treatment. 
This shifted Plk4-EGFP back to the faster migrating species 
(Fig. 3 F, right). Thus, Slimb depletion stabilizes a phosphory-
lated form of Plk4. Although we cannot completely rule out an 
indirect role for Slimb in regulating Plk4 levels, collectively, our 
Figure 3.  Plk4 is degraded in a Slimb-dependent manner and is stabilized by perturbing its interaction with Slimb. (A) Plk4 family showing the conserved 
kinase domain (gray), Polo box motif (striped boxes), and Slimb-binding consensus (black bars). The S293A/T297A SBM should be nondegradable.   
(B) Preimmune control and anti-Slimb immunoprecipitates from stable S2 cell lysates expressing Plk4-myc were probed for anti-Slimb, SkpA, and myc.   
(C) Control and anti-GFP immunoprecipitates from S2 cell lysates transiently expressing either inducible wild-type Plk4-EGFP or Plk4-SBM–EGFP were probed 
for endogenous Slimb. IP, immunoprecipitation. (D) Anti-GFP immunoprecipitates from S2 cell lysates transiently expressing triple Flag-ubiquitin and either 
inducible wild-type Plk4-EGFP or Plk4-SBM–EGFP were probed with anti-GFP (left) and anti-Flag (right) antibody. IB, immunoblot. (E) Anti-GFP immunoblots 
of lysates prepared from stable SAS-6p–driven Plk4-EGFP that were RNAi treated for the indicated protein for 7 d. (F) Plk4 is phosphorylated. (left) Anti-
GFP immunoblots of lysates from control or Slimb-depleted cells transiently expressing inducible Plk4-EGFP. Plk4 accumulates as a doublet (arrowheads) 
after slimb RNAi. (right) Anti-GFP immunoprecipitates from day 4 Slimb-depleted cells transiently expressing inducible Plk4-EGFP were mock or alkaline 
phosphatase treated. Plk4 shifts from a broad band (bracket) to a faster migrating single polypeptide (arrowhead). (D–F) Molecular mass is indicated in 
kilodaltons. (G) Anti-GFP immunoblots showing the levels of transiently expressed SAS-6p–driven Plk4-EGFP and Plk4-SBM–EGFP in 24-h drug-induced cell 
cycle–arrested cells. Cotransfected Nlp-EGFP was used as a loading control. (H) Anti-GFP immunoblots showing the levels of 4 h–induced Plk4-EGFP and 
Plk4-SBM–EGFP expression in drug-induced cell cycle–arrested cells. (E and H) -Tubulin was used as a loading control.231 PLK4 DEGREDATION BLOCKS CENTRIOLE REDUPLICATION • Rogers et al.
this somewhat elevated expression, Plk4-EGFP protein levels 
displayed a similar cell cycle profile as endogenous Plk4 mRNA, 
with the highest levels during mitosis (Fig. 3 G). These data 
suggest that the regulation of protein stability and transcrip-
tional regulation may both contribute to control Plk4 levels.
If Slimb regulates Plk4 protein levels, loss of Slimb regu-
lation should stabilize Plk4 protein throughout the cell cycle. To 
test this, we compared levels of Plk4-EGFP with that of Plk4-
SBM–EGFP with a mutated Slimb-binding domain. Plk4-
SBM–EGFP protein levels were higher than wild-type Plk4-GFP 
throughout the cell cycle whether we drove expression with the 
weak SAS-6p (Fig. 3 G and Fig. S3 E) or the strong metallothio-
nein-inducible promoter (Fig. 3 H). With the weaker SAS-6p, we 
also noted a Slimb-independent decrease in Plk4-SBM–EGFP 
levels during G2 (Fig. 3 G), suggesting a possible second mech-
anism of down-regulating Plk4 protein specifically during this cell 
cycle phase. These findings suggest that disrupting Plk4–Slimb 
interactions dramatically stabilizes Plk4 protein during interphase.
SBM Plk4 accumulates on centrioles 
throughout the cell cycle and promotes 
excess daughter centriole formation
Our data suggest the hypothesis that SCF
Slimb regulates Plk4 lev-
els on centrioles. To test this hypothesis, we expressed SAS-6p–
driven Plk4-SBM–EGFP and monitored its localization on 
centrioles during S, G2, and M phases. After arresting cells, 
Plk4-SBM–EGFP robustly accumulated at centrioles during all 
cell cycle phases that we examined (Fig. 4 D), in striking con-
trast to wild-type Plk4-EGFP (Fig. 4 C). Thus, mutating the 
Slimb-binding site stabilizes Plk4 on centrioles at cell cycle 
stages when it normally would be absent.
According to our hypothesis, Slimb can promote the local 
degradation of Plk4 at centrioles. Thus, both proteins should 
colocalize on centrioles. To test this, we transiently expressed 
Plk4-SBM–EGFP  and  immunostained  for  both  Slimb  and   
D-PLP. We found that Slimb and Plk4-SBM target centrioles in 
interphase cells as expected and colocalize (Fig. 5 A). These re-
sults support a model whereby Slimb can bind and ubiquitinate 
Plk4 directly on centrioles.
To test whether centrioles are required for the degradation 
of Plk4, we eliminated centrioles by sas-6 RNAi in cells ex-
pressing Plk4-EGFP and examined global Plk4 levels by Western 
blots. SAS-6 is an essential centriole component (Dammermann 
et al., 2004), and, previously, we have shown that sas-6 RNAi 
eliminates centrioles in S2 cells (Rogers et al., 2008). Remark-
ably,  although  Plk4-EGFP  is  stabilized  by  Slimb  depletion, 
Plk4-EGFP is not stabilized by sas-6 RNAi, remaining at the 
same levels as it was in controls (Fig. 5 B). Thus, centrioles are 
not apparently required for Plk4 down-regulation.
Our hypothesis suggests that Slimb-mediated destruction 
of Plk4 is critical for limiting centriole duplication. One predic-
tion of this is that a Plk4 mutant that cannot be targeted by 
Slimb should drive centriole reduplication, increasing centriole 
number. To test this, we examined cycling cells expressing Plk4-
SBM–EGFP. Strikingly, these cells steadily increased their inter-
phase centriole number over a 5-d time course (as measured 
using D-PLP immunostaining), reaching a level double that of 
SAS-6 promoter (SAS-6p). Immunoblotting confirmed that 
Plk4 RNAi reduced protein levels by 84%, whereas slimb RNAi 
produced massive Plk4 accumulation (Fig. 3 E). Plk4 depletion 
dramatically reduced centriole number (Figs. S1 C and S3 B) as 
previously described (Bettencourt-Dias et al., 2005). Codeple-
tion of Plk4 and Slimb also eliminated centrioles (Figs. S1 C 
and S3 B). Thus, Plk4 is required for centriole reduplication in 
Slimb-depleted cells.
Plk4 levels on centrioles are high during 
mitosis and undetectable at S phase
Plk4 localizes to centrioles (Bettencourt-Dias et al., 2005). If 
Plk4 regulates the timing of centriole duplication, its centriole 
localization should be tightly regulated through the cell cycle. To 
assess this, we drove Plk4-EGFP using the weak SAS-6p, which 
is expressed throughout the cell cycle (unpublished data). Be-
cause of its low expression, identifying Plk4-EGFP–transfected 
cells was made possible by cotransfecting with the abundant 
nuclear protein nucleophosmin (Nlp)-EGFP (Ito et al., 1996). 
Notably, unlike mammalian Nlp, which localizes to centrosomes 
and suppresses their overduplication (Okuda et al., 2000; Wang 
et al., 2005), Drosophila Nlp does not localize to centrioles 
(Fig. S2 E), and nlp RNAi has no effect on centriole number (not 
depicted). We found that Plk4-EGFP was asymmetrically local-
ized on D-PLP–labeled centrioles in interphase (Fig. 4 A), as 
seen in mammalian cells (Kleylein-Sohn et al., 2007). To assess 
whether Plk4 centriole localization is cell cycle regulated, we 
coexpressed Plk4-EGFP and mCherry–SAS-6 in cells chemi-
cally arrested during S, G2, or M phase (Fig. 4, B and C). Plk4 
was undetectable in S phase–arrested cells, whereas levels on 
centrioles peaked during mitotic arrest (Fig. 4 C). Plk4-EGFP 
was observed on centrioles in some but not all cycling interphase 
cells (Fig. 4 A), a population presumably lost after prolonged   
interphase drug arrest. Thus, whereas Slimb localizes to centrioles 
during interphase, Plk4 on centrioles peaks during mitosis, and it 
is not detected there during S phase. This is consistent with the 
hypothesis that Slimb on centrioles can destabilize Plk4 during a 
period of the cell cycle when centriole duplication occurs.
The expression of mouse Plk4 is cell cycle regulated (Fode 
et al., 1996), providing an additional mechanism for regulating 
its levels. Like mouse Plk4, fly Plk4 mRNA is expressed during 
S phase and peaks during mitosis (as assessed by RT-PCR of S2 
cells  arrested  during  different  cell  cycle  stages;  Fig.  S3  C). 
These data suggest that transcriptional regulation cannot fully 
account for the differences in centrosomal localization we ob-
served. In our localization experiments, we expressed Plk4 
using SAS-6p, which is expressed at roughly equal levels 
throughout the cell cycle (unpublished data). We wanted to en-
sure that expression via SAS-6p did not artificially reduce Plk4 
levels to a point at which it might be subject to regulatory mech-
anisms that do not normally regulate endogenous Plk4. In fact, 
quantitative RT-PCR revealed that SAS-6p Plk4-EGFP mRNA 
was expressed at levels 10–20 times higher than that of endoge-
nous mRNA (Fig. S3 D). However, these levels are not suffi-
cient to alter centrosome number over time (Table I), in contrast 
to high level overexpression of Plk4, which increases centriole 
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expressing Plk4-SBM–EGFP contained a mixed population of 
centrioles decorated with either one or two Plk4-SBM–EGFP 
spots (Fig. 5, A, C, and D), which is in contrast to wild-type 
Plk4-EGFP–expressing cells in which only one spot was seen 
(Fig. 4 A). The presence of multiple Plk4 centriole-associated 
spots in cells where Slimb–Plk4 interaction is perturbed sug-
gested  a  mechanism  underlying  excess  centriole  duplication 
wild type, whereas cells expressing Plk4-EGFP retained wild-
type centriole numbers (Table I and Fig. 5, C and D). These data 
strongly support the hypothesis that Slimb acts through Plk4 to 
regulate centriole number.
Another interesting issue is how Plk4 promotes centriole 
duplication and how this is limited to once per cell cycle. Our 
imaging analysis provided insight into this mechanism. Cells 
Figure 4.  Slimb regulates Plk4 levels on centrioles to control centriole number. (A) Asymmetrical Plk4 localization. Transient coexpression of Nlp-EGFP 
(Ito et al., 1996) as a cotransfection marker (green) labeling nuclei (arrow) and Plk4-EGFP (green). D-PLP (red) marks centrioles (arrowheads). Insets show 
centrioles at a higher magnification. (B–D) Mutating the Slimb-binding site stabilizes Plk4 on centrioles. (B) Cell cycle distributions after 24-h drug-induced 
S, G2, or mitotic arrest. Histograms are shown to scale and were assessed by HTM (5,000 cells/histogram). (C) Plk4-EGFP (green) only localizes to   
M-phase centrioles (arrowheads and insets) marked with mCherry–SAS-6 in live cells (red). Condensed DNA (blue) reveals mitotic cells. (D) Plk4-SBM–EGFP 
(green) localizes to centrioles during all cell cycle phases that were examined. Centrioles (arrowheads and insets) are marked with D-PLP in fixed cells (red). 
Nlp-EGFP (green nuclei, cytoplasmic during mitosis) is the cotransfection control. Bars: (A) 5 µm; (C and D) 2.5 µm.233 PLK4 DEGREDATION BLOCKS CENTRIOLE REDUPLICATION • Rogers et al.
depleted of both Slimb and Plk4 (Table II), showing that Plk4 is 
necessary for evading the block (but not required to maintain cen-
triole integrity during S-phase arrest). To test whether Plk4 accu-
mulation at centrioles is sufficient for evading the S-phase block, 
we expressed Plk4-SBM–EGFP in S phase–arrested cells. Strik-
ingly, median centriole number increased over time, reaching a 
level threefold higher than wild type (Table I). In contrast, centri-
ole number was maintained at wild-type levels in cells expressing 
Plk4-EGFP  (Table  I). Thus,  SCF
Slimb  regulates  Plk4  levels  to 
maintain an S-phase block to centriole reduplication.
Discussion
Limiting centriole duplication to once and only once per cell 
cycle is a key event in all eukaryotes, ensuring that cells form a 
bipolar spindle and correctly segregate their chromosomes. De-
fects in this can cause genomic instability and may contribute   
to cancer. Despite more than a century of interest in this issue 
(Boveri, 1929) and despite advances in understanding the cen-
trosome cycle (Tsou and Stearns, 2006b), mechanisms limiting 
centrosome duplication remain largely mysterious. In this study, 
we describe a mechanism accomplishing this goal, in which the 
SCF
Slimb ubiquitin ligase regulates stability of the key centro-
some regulator Plk4, allowing it to stimulate centrosome dupli-
cation and then degrading it to prevent reduplication.
A novel mechanism for regulating 
centrosome duplication
One mechanism limiting DNA replication to once and only 
once per cell cycle involves E3 ubiquitin ligases that regulate 
stability of replication licensing factors. When we began, there 
were indications that several E3 ubiquitin ligases might also regu-
late centrosome duplication, as mutations in SkpA and the F-box 
proteins Slimb and Skp2 affect centrosome number (Wojcik 
et al., 2000; Nakayama et al., 2000; Guardavaccaro et al., 2003; 
Murphy, 2003). We comprehensively examined all identifiable 
fly Roc, Cullin, Skp, and F-box proteins using two different 
screens to sort out primary regulators of the centrosome cycle 
from those affecting cell cycle progression. The results were 
striking: SCF
Slimb plays a key role in regulating centriole num-
ber, as mutations in all subunits affect this. In contrast, none of 
whereby  mother  centrioles  may  assemble  more  than  one   
daughter centriole at a time. Thus, we examined Plk4-SBM–
EGFP-expressing cells by EM. Strikingly, we found examples 
of mother centrioles associated with two or more daughter cen-
trioles (Fig. 5, E and F), which is something we never observed 
in wild type. Collectively, these data suggest that SCF
Slimb regu-
lates Plk4 accumulation on centrioles in a cell cycle–dependent 
manner and that if Slimb recognition is perturbed, overduplica-
tion can occur by mother centrioles simultaneously assembling 
multiple daughter centrioles.
Slimb maintains an S-phase reduplication 
block by down-regulating Plk4 on centrioles
Normal cells can block centriole reduplication even after pro-
longed S-phase arrest, whereas some cancer cells lose the abil-
ity  to  block  reduplication  (Balczon  et  al.,  1995;  Wong  and 
Stearns, 2003; Loncarek et al., 2008). The molecular mecha-
nism remains unclear. We hypothesized that SCF
Slimb mediates 
this block by down-regulating Plk4. To test this, we treated S2 
cells chemically arrested in S phase with RNAi and counted   
D-PLP centrioles over a 5-d time course (Table II). Control S2 
cells possess a block to reduplication, as centriole numbers re-
mained constant during the time course; plk4 RNAi does not af-
fect this block. However, after slimb RNAi, centriole numbers 
gradually increased over time. Plk4-EGFP was not present in   
S phase–arrested control RNAi–transfected cells where Slimb is 
active (Fig. 5 G, left) but was detected on centrioles in S phase–
arrested  cells  treated  with  the  proteasome  inhibitor  MG132 
(Fig. 5 H). Strikingly, Plk4-EGFP reappeared on centrioles in 
Slimb-depleted S phase–arrested cells (Fig. 5 G, right). This 
also suggests that Slimb is not required for Plk4 to target centri-
oles. Thus, Slimb is required during S phase to block centriole 
number from increasing over time (Slimb might also affect sep-
aration of centriole pairs, as our visualization methods cannot 
distinguish centriole singlets and doublets; however, our afore-
mentioned EM analysis suggests that if it does so, it also regu-
lates duplication). Slimb depletion allows Plk4 accumulation on 
centrioles and abrogates this block.
As a final test, we examined whether Plk4 accumulation is 
necessary and sufficient to evade the S-phase block to centriole 
reduplication. Centriole number did not increase in cells co-
Table I.  Effects of wild-type Plk4 and SBM-Plk4 expression on centriole number
Day Cycling cells
a S phase–arrested cells
b
Plk4-EGFP Plk4-SBM–EGFP Plk4-EGFP Plk4-SBM–EGFP
Total Mean  
± SD
Median Total Mean  
± SD
Median Total Mean  
± SD
Median Total Mean  
± SD
Median
1 100 2.9 ± 3.9 2.0 104 3.5 ± 3.4 2.0 100 3.1 ± 3.1 2.0 100 3.9 ± 4.2 2.0
2 112 2.6 ± 3.0 2.0 104 4.3 ± 4.2
c 3.0 101 3.5 ± 3.2 2.0 100 4.7 ± 5.3 4.0
3 111 3.1 ± 2.7 2.0 103 5.3 ± 4.0
c 4.0 100 3.1 ± 3.7 2.0 101 5.1 ± 4.4
c 4.0
4 113 3.0 ± 2.4 2.0 111 5.3 ± 3.4
c 5.0 100 3.4 ± 3.7 2.0 100 6.1 ± 5.0
c 5.0
5 97 3.2 ± 2.8 2.0 100 7.1 ± 5.8
c 6.0 100 2.8 ± 2.7 2.0 100 6.4 ± 5.2
c 6.0
Expression of Plk4-EGFP and Plk4-SBM–EGFP was driven off of the weak SAS-6p. Positive transfected cells were identified by cotransfection with a plasmid expressing the nuclear 
protein Nlp-EGFP. Total, total cell number; mean and median columns refer to centriole number.
aCentrioles were counted beginning 24 h after transfection.
b24 h after transfection, cells were treated with aphidicolin/HU to arrest them through the time course of this experiment. Centrioles were quantified beginning 48 h after transfection.
cIndicates a significant difference using an unpaired t test (P < 0.001).JCB • VOLUME 184 • NUMBER 2 • 2009   234
Figure 5.  Stable Plk4 promotes excess daughter centriole formation, and slimb RNAi eliminates the S-phase centriole reduplication block by accumulating 
Plk4 on centrioles. (A) Slimb overlaps Plk4-SBM–EGFP localization on centrioles. Immunostaining of Slimb (red) and D-PLP centrioles (blue) in a transiently 
expressing coexpressing Nlp-EGFP (green nuclei) and SAS-6p Plk4-SBM–EGFP (green) interphase S2 cell. A representative centriole (arrowhead) is shown 
at a higher magnification (inset). (B) Anti-GFP immunoblots of lysates prepared from transiently expressing inducible Plk4-EGFP that were RNAi treated 
for the indicated proteins for 7 d. -Tubulin was used as a loading control. Molecular mass is indicated in kilodaltons. (C and D) Transient coexpression 
of Nlp-EGFP (green nuclei) and Plk4-SBM–EGFP in day 5 cycling S2 cells. Plk4-SBM–EGFP labels one or more spots (green) on D-PLP–stained centrioles 235 PLK4 DEGREDATION BLOCKS CENTRIOLE REDUPLICATION • Rogers et al.
that one or more cell cycle–regulated kinases phosphorylate 
Plk4, priming it for recognition by SCF
Slimb at times other 
than during mitosis. This is consistent with the mechanisms 
by  which  SCF
Slimb  recognizes  other  targets  and  consistent 
with the effect of our point mutations in two conserved serine/
threonine residues in the Slimb-binding motif. It will be im-
portant to identify these kinases and determine how they are 
regulated,  assessing  phosphorylation  and  ubiquitination  in 
vivo and in vitro. It will also be important to explore how 
Slimb recruitment to centrioles is regulated and whether this 
is dependent on Plk4 kinase activity.
Determining where Plk4 ubiquitination occurs is another 
important issue. Plk4 is a protein of low abundance and is only 
detected on centrioles, whereas Slimb is a relatively abundant 
cytoplasmic and nuclear protein that is also enriched on centri-
oles. Our hypothesis is that SCF
Slimb ubiquitinates a phosphory-
lated form of Plk4 directly on centrioles to control centriole 
duplication, although this need not be the case. We found that 
Plk4 is efficiently degraded when driven under a strong induc-
ible promoter in cells that contain or lack centrioles. Therefore, 
it is likely that cytosolic SCF
Slimb can recognize and degrade 
Plk4 as long as the phosphorylation state of Plk4 permits this. 
Indeed, the ability of SCF
Slimb to globally promote Plk4 degra-
dation may be crucial in suppressing de novo centriole assem-
bly, a unique activity of Plk4 (Rodrigues-Martins et al., 2007). 
Thus, it will be important to determine the role of SCF
Slimb in 
regulating  de  novo  centriole  assembly,  a  phenomena  that  is 
poorly understood. Although centrioles appear dispensable for 
Plk4 degradation, these results do not negate the possibility that 
Slimb normally promotes the local degradation of Plk4 directly 
at centrioles.
This mechanism to prevent centriole reduplication may 
be conserved in mammals. Cells lacking -Trcp1 (mammalian 
the other proteins tested played a key role in regulating centro-
some number under the conditions of our screen, with the 
exception of Skp2. Cells from Skp2-null mice display super-
numerary centrosomes and an altered cell cycle geared toward 
DNA endoreduplication (Nakayama et al., 2000). In our screen, 
skp2 RNAi did not affect interphase centriole number but in-
creased  mitotic  centrosome  number  and  induced  endocycles 
(unpublished data). Thus, SCF
Slimb appears to be the sole identi-
fiable Cullin-based ubiquitin ligase regulating centriole number; 
however, it is possible that roles for other F-box proteins are 
hidden by potential redundancy between different F-box proteins.
Given these data, we pursued the identity of the Slimb 
target, searching for candidate proteins with a Slimb-binding 
consensus. This led us to Plk4. Our data reveal a novel mech-
anism for limiting centriole duplication to once per cell cycle, 
suggesting  a  model  in  which  Plk4  levels  are  regulated 
throughout the cell cycle by ubiquitin-mediated proteolysis 
via SCF
Slimb (Fig. 6). Throughout the cell cycle, the F-box 
protein Slimb resides on centrioles, which are primed to de-
grade  Plk4.  During  mitosis,  Plk4  localizes  to  centrioles, 
where it presumably phosphorylates an unknown centriole 
substrate required to initiate duplication later in the cell cycle. 
(We note that the levels of Slimb and Plk4 on centrioles have 
not been determined during G1 phase. In an asynchronous S2 
population, however, anti-Slimb staining is detected on cen-
trioles in every cell we have examined.) At some point after 
mitotic exit (likely during G1 phase), Plk4 levels fall as a re-
sult of SCF
Slimb-mediated proteolysis (this may occur through-
out the cell or on centrioles). During S and G2 phases, Slimb 
on centrioles prevents Plk4 centriole accumulation and blocks 
reduplication. During the subsequent M phase, Plk4 levels 
rise  and  Plk4  reassociates  with  centrioles.  Although  both 
Slimb and Plk4 localize to mitotic centrioles, we hypothesize 
(red). Insets show select centrioles at a higher magnification. The cell in D shows an extreme example of centriole overduplication. White tracing marks cell 
borders. (E and F) Transmission electron micrographs of interphase cells expressing Plk4-SBM–EGFP for 5 d. Red arrows denote excess daughter centrioles 
emanating from mother centrioles shown in the cross section. The cell in E shows a normal mother–daughter centriole pair (orange arrow) adjacent to a 
mother with two daughters. Illustrations of these centrioles are shown in E and F. (G) Transient expression of Plk4-EGFP/Nlp-EGFP (green) in day 3 RNAi-
treated cells arrested in S phase for 2 d. D-PLP–labeled centrioles (red, arrowheads). Insets show centrioles at a higher magnification. (H) Stable expression 
of Plk4-EGFP (green) in a 24-h S phase–arrested cell treated with MG132 proteasome inhibitor. Insets show select D-PLP–labeled centrioles (red) at a higher 
magnification. Bars: (A–D) 5 µm; (E and F) 0.2 µm; (G and H) 2.5 µm.
 
Table II.  Quantitation of centriole number in S phase–arrested RNAi-treated S2 cells
Day
a Control RNAi slimb RNAi plk4 RNAi plk4/slimb RNAi
Total Mean  
± SD
Median Total Mean  
± SD
Median Total Mean  
± SD
Median Total Mean  
± SD
Median
0 159 2.8 ± 3.0 2.0 173 3.2 ± 4.0 2.0 170 2.9 ± 3.5 2.0 171 2.8 ± 3.6 2.0
1 148 2.6 ± 2.9 2.0 169 3.0 ± 3.3 2.0 175 2.6 ± 2.9 2.0 172 2.5 ± 3.2 2.0
2 181 2.3 ± 2.1 2.0 169 2.8 ± 3.1 2.0 166 2.8 ± 3.2 2.0 186 2.7 ± 2.8 2.0
3 169 2.5 ± 2.5 2.0 179 3.4 ± 3.4
b 3.0 170 2.4 ± 2.5 2.0 171 2.9 ± 3.8 2.0
4 157 2.2 ± 2.3 2.0 157 3.9 ± 3.8
b 3.0 160 2.6 ± 2.9 2.0 160 2.4 ± 3.1 2.0
5 150 2.4 ± 2.2 2.0 126 4.4 ± 3.8
b 4.0 142 2.4 ± 4.0 2.0 154 2.3 ± 3.3 2.0
Total, total cell number; mean and median columns refer to centriole number.
aCells were treated with 10 µg dsRNA, 10 µM aphidicolin, and 1.5 mM HU and processed for D-PLP immunofluorescence. This procedure was started on day 0 and repeated 
every 24 h.
bIndicates a significant difference in the mean centriole value compared with the control population using an unpaired t test (P < 0.003).JCB • VOLUME 184 • NUMBER 2 • 2009   236
primes centrioles for duplication later during S phase. Recent 
work analyzing centriole duplication after laser ablation of cen-
trioles during S-phase arrest may support this hypothesis (Loncarek 
et al., 2008). After destruction of the daughter in a centriole pair, 
mother centrioles retained the ability to duplicate a new daughter. 
However, daughter centrioles could not duplicate after the 
destruction of their associated mother. Although there are other 
possible interpretations such as a role for PCM in centriole as-
sembly (Loncarek et al., 2008), our priming model could also 
account for this difference. Mother centrioles would still possess 
the modification they received during the previous mitosis, 
allowing duplication. Laser ablating the daughter could ex-
pose this site, permitting duplication. However, because daughter 
centrioles have not yet received a Plk4 modification, duplication 
cannot occur after destruction of the mother.
Our data also suggest a possible molecular mechanism. 
Plk4 is asymmetrically localized on centrioles in both flies (our 
unpublished data) and mammals (Kleylein-Sohn et al., 2007), 
and this placement could define the site of daughter initiation. 
Furthermore, cells lacking Slimb sometimes had two spots of 
Plk4 on centrioles, and mothers were observed with multiple asso-
ciated daughters. Perhaps Slimb helps limit Plk4 to a single high 
affinity site, ensuring that its putative substrate is also spatially 
Slimb) have excess centrosomes (Guardavaccaro et al., 2003). 
Human Plk4 is required for centriole duplication (Habedanck 
et al., 2005), and Plk4 overexpression produces mother centri-
oles associated with multiple daughters (Kleylein-Sohn et al., 
2007), which is similar to the centriole configurations we ob-
served by perturbing Slimb–Plk4 association. Moreover, in-
hibiting the proteasome in human cells also produces mother 
centrioles  attached  to  multiple  daughters  (Duensing  et  al., 
2007). It will be important to assess which features of our 
mechanism are conserved. Our proposed mechanism is differ-
ent, but not mutually exclusive, from that described by Tsou 
and Stearns (2006b), who used an in vitro assay to identify a 
block to reduplication intrinsic to centriole conformation in 
which separation of centriole pairs during mitotic exit is re-
quired for S-phase duplication. We also note that we cannot 
rule out a separate role for Slimb in regulating centriole dis-
engagement. Premature disengagement would also elevate ap-
parent centriole number. It will be important in the future to 
examine this possibility.
Plk4 localizes asymmetrically on centrioles (Kleylein-Sohn 
et al., 2007), perhaps indicating a preferred binding site or nearby 
scaffold where Plk4 modifies its substrates (Rodrigues-Martins 
et al., 2007). We propose that during mitosis, Plk4 modifies and 
Figure 6.  Speculative model for a mechanism 
to limit centriole duplication to once per cell 
cycle by modulating the levels of Plk4 on cen-
trioles through the activity of the SCF
Slimb ubiq-
uitin ligase. (1) Plk4 levels on centrioles peak 
during mitosis but also appear asymmetrically 
positioned  on  centrioles  in  a  subpopulation 
of interphase cells. At this time, Plk4 activity 
initiates the duplication process by ”priming” 
centrioles for the duplication event that occurs 
later in the cell cycle. This could be achieved 
by  targeting  or  stabilizing  a  key  centriolar 
subunit to the parent centriole that then lays 
the foundation to assemble a procentriole. Dur-
ing mitotic exit, centriole pairs separate (dis-
engage),  thereby  releasing  centriole  singlets 
into  the  interphase  cytoplasm  (Callaini  and 
Riparbelli, 1990). Although Slimb localizes to 
centrioles during all of the cell cycle phases 
that we examined, Plk4 is not phosphorylated 
on residues required for Slimb binding during 
mitosis  and  is  thus  stable.  (2)  As  cells  com-
plete cytokinesis, centriole singlets shed their 
PCM  and  lack  microtubule  nucleating  activ-
ity (Rogers et al., 2008). During interphase, 
Plk4 is phosphorylated and now recognized 
by SCF
Slimb, leading to its ubiquitination and 
degradation.  Levels  of  centriole-associated 
Plk4 are low at this time. However, centrioles 
retain a critical modification (shown in purple) 
endowed upon them by Plk4 and are compe-
tent to duplicate. We note that Slimb and Plk4 
levels on centrioles have not been determined 
during G1 phase. (3) Centrioles duplicate just 
before or during S phase with the appearance 
of a procentriole. Slimb on centrioles ensures 
that Plk4 levels remain low at this time and thus 
block centriole reduplication. (4) During G2, 
daughter centrioles elongate. Slimb at centri-
oles continues to prevent Plk4 accumulation.237 PLK4 DEGREDATION BLOCKS CENTRIOLE REDUPLICATION • Rogers et al.
T. Murphy), GFP JL-8 (Clontech Laboratories, Inc.), myc 9E10 (Developmen-
tal Studies Hybridoma Bank), Cullin-1 (Invitrogen), Cullin-4 (provided by   
S. Zacharek and Y. Xiong, University of North Carolina at Chapel Hill, Cha-
pel Hill, NC), E2F1, Roc1a, Cullin-5 (provided by R. Duronio, University of 
North Carolina at Chapel Hill, Chapel Hill, NC), and Plk4 (provided by M. 
Bettencourt-Dias, Instituto Gulbenkian de Ciencia, Oeiras, Portugal). The 
percentage of depletion of the target protein was measured using the den-
sitometry functions of ImageJ.
Antibody production
Escherichia coli–expressed GST- or maltose-binding protein–Slimb (amino 
acids 1–91) proteins were purified on either glutathione-Sepharose or amy-
lose resin. Guinea pig polyclonal antisera (provided by T. Murphy) were 
raised against GST-tagged purified fusion protein, and the corresponding 
maltose-binding protein fusion was used for antibody affinity purification 
by precoupling to Affigel 10/15 (Bio-Rad Laboratories). Antibodies were 
affinity purified by elution with low pH buffer.
Immunoprecipitation
Polyclonal and monoclonal antisera were bound to equilibrated protein A– 
or protein G–Sepharose (Sigma-Aldrich), respectively, by gently rocking 
overnight at 4°C in 0.2 M sodium borate. In some cases, the prebound an-
tibody was cross-linked to the resin using dimethyl pimelimidate by rocking 
for 1 h at 22°C, and the coupling reaction was quenched in 0.2 M etha-
nolamine, pH 8.0, by rocking for 2 h at 22°C. Antibody-coated beads 
were washed three times with 1.5 ml of cell lysis buffer (CLB; 50 mM Tris, 
pH 7.2, 125 mM NaCl, 2 mM DTT, 0.1% Triton X-100, and 0.1 mM 
PMSF). Transfected S2 cells were induced to express recombinant Plk4 
with 350–500 mM CuSO4 in the presence of 30 µM MG132. Cells were 
then lysed in CLB, precleared, and diluted to 2–5 mg/ml in CLB. Antibody-
coated beads were mixed with lysate for 40 min at 4°C, washed three 
times with 1 ml CLB, and boiled in SDS-PAGE sample buffer. Alkaline phos-
phatase (New England Biolabs, Inc.) treatments were performed for 30 
min at 37°C. In vivo ubiquitination assays were performed by coexpress-
ing  Plk4-EGFP  constructs  with  triple  Flag-tagged  Drosophila  ubiquitin 
(CG32744), driven under the fly actin (Act5) promoter, immunoprecipi-
tated using anti-GFP antibody (Clontech Laboratories, Inc.), and analyzed 
by anti-Flag (Sigma-Aldrich) immunoblots.
Constructs and transfection
Endogenous promoters for GFP and mCherry constructs were made by 
PCR of genomic regions upstream of Slimb (960 bp), Nlp/CG7919 (429 
bp; Ito et al., 1996), or SAS-6 (208 bp) and subcloned into pMT vectors 
(Invitrogen). Plk4-myc and Plk4-EGFP constructs were expressed either by 
the addition of 350 or 500 µM copper sulfate to the media to induce the 
metallothionein promoter or were under control of the low-expressing SAS-6p. 
QuikChange II (Agilent Technologies) was used to generate the Plk4 
SBMs. Stable cell lines were generated using Effectene transfection reagent 
(QIAGEN)/pCoHygro selection system (Invitrogen). All stable cell lines ex-
pressing fluorescent proteins will be made available through the Drosoph-
ila  Genomics  Resource  Center.  Transient  transfections  were  performed 
using the Nucleofector II (Amaxa) apparatus.
Live cell microscopy
S2 cells were plated on 0.5 mg/ml Con A–coated glass-bottom dishes (Mat-
Tek) for 1 h before observation. Cells were imaged with a 100× NA 1.45 Plan 
Apochromat objective using a microscope (TE2000-E) equipped with a cooled 
charge-coupled device camera (CoolSNAP HQ; Photometrics). Images were 
collected using MetaMorph software (MDS Analytical Technologies).
Centriole purification
Centrioles were purified exactly as described by Mitchison and Kirschner 
(1986).
Transmission EM
RNAi-treated S2 cells were plated as monolayers on Con A–treated poly-
styrene plates that were rinsed with PBS and fixed in 3% glutaraldehyde 
with 0.1 M sodium cacodylate, pH 7.4, for several hours or overnight.   
After buffer washes, the monolayers were postfixed for 1 h with 1% osmium 
tetroxide, 1.25% potassium ferrocyanide, and 0.1 M sodium cacodylate 
buffer. The cells were dehydrated using increasing concentrations of etha-
nol, infiltrated, and embedded in Polybed 812 epoxy resin (Polysciences, 
Inc.). The blocks were sectioned parallel to the substrate at 70 nm using a 
diamond knife, and the sections were mounted on 200 mesh copper grids 
followed by staining with 4% aqueous uranyl acetate and Reynolds’ lead 
citrate. Sections were observed with a transmission electron microscope 
limited, resulting in the production of only a single daughter. An 
important goal will be to identify how Plk4 is targeted to centri-
oles and to identify its substrates there.
Possible parallels between centriole duplication and DNA 
replication are intriguing. Both occur once per cell cycle and are 
blocked from reinitiating by Cullin-based proteasomal targeting 
of critical regulators. Alterations or inactivation of the regulatory 
mechanism we describe may underlie the ability of some cells, 
like multiciliated cells, to increase centriole number, and mis-
regulation of this pathway may also contribute to centrosome 
amplification and genomic instability during tumorigenesis.
Materials and methods
Cell culture and double-stranded RNAi
Drosophila S2 cell culture and RNAi were performed as described previ-
ously (Rogers and Rogers, 2008). Gene-specific primer sequences used to 
generate double-stranded RNA (dsRNA) are shown in Table S2 (available 
at http://www.jcb.org/cgi/content/full/jcb.200808049/DC1). In brief, 
cells were cultured in Sf900II serum-free media (Invitrogen) without FBS. 
RNAi was conducted in 6-well plates, and cells (50–90% confluency) were 
treated with 10 µg dsRNA in 1 ml of media and replenished with fresh   
media/dsRNA every day for 7 d. Cell cycle arrest was induced by treating 
cells for at least 24 h with a final concentration of either 1 µM hydroxyurea 
(HU) + 10 µM aphidicolin (S phase), 1.7 µM 20-hydroxyecdysone (G2 
phase), or 30 µM colchicine (mitosis). Colchicine treatment produces a mi-
totic index of 20–30%, and, in some cases, Hoechst 33342 (Invitrogen) 
was added at a final concentration of 16.2 µM to identify mitotic cells con-
taining condensed chromosomes. The cell cycle profiles in Figs. 2 F and 4 B 
are consistent with arrest at the stages indicated; HU/aphidicolin-arrested 
cells have a strong G1 peak and a small G2 peak, whereas ecdysone- and 
colchicine-arrested cells have a strong G2 peak. Cells were treated with 
30 µM MG132 for 24 h.
RT-PCR
Total RNA was isolated from untransfected or SAS-6p Plk4-EGFP stable 
S2 cells using TRIZOL (Invitrogen). RNA was DNase treated for 30 min 
at 37°C followed by DNase inactivation for 10 min at 65°C. cDNA was 
generated from 1 µg of total RNA using standard conditions, and PCR 
was performed for Plk4 and Rp49 at 94°C for 30 s, 57°C for 30 s, and 
72°C for 1 min. For semiquantitative RT-PCR, aliquots were removed at cycles 
18, 20, 22, 24, 26, 28, and 30, and band intensity was determined using 
ImageJ software (National Institutes of Health). The following primers were 
used:  Plk4  forward,  5-ATAGAGCACGGAAACGAGTG-3;  Plk4  reverse,   
5-TGCCGAAGTGGGTTGAAG-3;  Rp49  forward,  5-ATCCGCCCAG-
CATACAGG-3; and Rp49 reverse, 5-CTCGTTCTCTTGAGAACGCAG-3.
Immunofluorescence microscopy
For immunostaining, S2 cells were fixed and processed exactly as de-
scribed previously (Rogers and Rogers, 2008) by prespreading S2 cells 
on Con A–coated glass-bottom dishes and fixing with either cold metha-
nol or formaldehyde (10% final). Antibodies used in this study were di-
luted to concentrations ranging from 1 to 20 µg/ml and include Slimb 
(provided by T. Murphy, Carnegie Institute of Washington, Baltimore, 
MD), SAS-6 and D-PLP (produced in our own laboratory; Rogers et al., 
2008),  -tubulin  DM1a  (Sigma-Aldrich),  -tubulin  GTU-88  (Sigma- 
Aldrich), and phosphohistone H3 (Cell Signaling Technology). Secondary 
antibodies Cy2 and rhodamine red (Jackson ImmunoResearch Laborato-
ries) were used at final dilutions of 1:100. Cells were mounted in a 0.1-M 
propyl gallate-glycerol solution. DAPI (Sigma-Aldrich) was used at a final 
concentration of 5 µg/ml. Specimens were imaged using a microscope 
(TE2000-E; Nikon).
Immunoblotting
S2 cell extracts were produced by resuspending cell pellets in PBS + 0.1% 
Triton X-100, and a small amount was removed to measure protein concen-
tration. SDS-PAGE sample buffer was added and boiled for 5 min. The effi-
ciency of RNAi was determined by Western blotting lysates in which equal 
protein  amounts  were  loaded  and  bands  were  normalized  using  anti-
bodies against -tubulin. Antibodies used in this study were diluted to 
concentrations ranging from 1 to 20 µg/ml and include SkpA (provided by JCB • VOLUME 184 • NUMBER 2 • 2009   238
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(EM910; LEO Electron Microscopy) operating at 80 kV and photographed 
using a charge-coupled device digital camera (Orius SC1000; Gatan, 
Inc.) and Digital Micrograph 3.11.0 (Gatan, Inc.).
HTM
S2  cells  were  seeded  in  Con  A–coated  24-well  glass-bottom  plates 
(Greiner) for 1 h before fixation, stained (as described in Immunofluores-
cence  microscopy),  and  scanned  with  an  Array  Scan  V  (Cellomics) 
equipped with a 20× NA 0.5 or 40× NA 0.95 objective and a cooled 
charge-coupled device camera (ORCA-ER; Hamamatsu Photonics). Images 
of 5,000 cells per well were acquired and analyzed using vHCS View 
(Cellomics).  Integrated  fluorescence  intensity  measurements  were  deter-
mined from unsaturated images.
Online supplemental material
Fig. S1 provides additional information regarding the Cullin-based RNAi 
screen performed in this study, which includes Western blots demonstrat-
ing the efficiency of RNAi, measurements of interphase centriole number, 
and frequencies of multipolar spindle formation. An illustration of the ver-
tebrate canonical centrosome cycle is also shown to provide an introduc-
tion to the field of centrosome duplication. Fig. S2 provides additional 
phenotypic data of Slimb RNAi in S2 cells, which include distribution 
histograms of centriole number and Slimb immunostaining in RNAi-treated 
cells. A time series of S2 cell mitosis and several micrographs that show 
the centriole (and nuclear) markers used in the study are included. Fig. S3 
shows additional data characterizing Drosophila Plk4 expression levels 
(both message and protein titers) as well as RNAi-induced phenotypes in 
S2 cells. Table S1 shows the results of the first Cullin-based RNAi screen 
performed in this study and lists the measurements of mitotic centrosome 
number in each RNAi treatment. Table S2 shows a list of all of the primer 
sequences used to generate the dsRNA templates in this study. Video 1   
shows the colocalization of Slimb-GFP to a single centriole in a live   
S2  cell.  Online  supplemental  material  is  available  at  http://www.jcb 
.org/cgi/content/full/jcb.200808049/DC1.
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